First large-scale study reporting OS with Lu-PSMA-617 (Pluvicto) in clinical setting. Similar OS regardless of age, race/ethnicity, number or type of metastasis. Listen for my take on why real world data is so important for our older patients. Median age in study = 69 yo. #GU25 @DukeCancer
15.02.2025 17:38 — 👍 3 🔁 0 💬 0 📌 0
Dan George, MD at Duke Cancer Institute
@dangeorgemd.bsky.social
I study and treat GU cancers (prostate, kidney, bladder); FASCO; Duke BS, MD, and BB Fan; husband, father, swimmer. Opinions=mine. https://duke.is/NewsfromYourGUrus
57 Followers |
21 Following |
1 Posts |
Joined: 15.02.2025 |
1.1544
